When his dog was diagnosed with cancer, he decided to look for unconventional solutions. Using artificial intelligence, he searched for potential treatments. The experimental vaccine ended up delivering results that even surprised scientists.
Rosie's story shows where medicine is headed today. Her owner, Paul Conyngham from Australia, adopted her back in 2019. A few years later, she was diagnosed with a serious illness: an aggressive form of mast cell tumor.
They tried the usual treatments. Surgery and chemotherapy slowed things down, but the tumor didn’t go away. So, Paul started thinking about how he could help his dog and searched for new solutions. In the end, he decided to take a different path and involve technology, including artificial intelligence, reports Interesting Engineering.
Paul, along with researchers from the University of New South Wales, conducted a genetic analysis of the tumor. This revealed specific mutations responsible for its growth. Based on this data, they developed a tailor-made treatment plan.
The key player was an mRNA vaccine designed by a team led by expert Palli Thordarson from the UNSW RNA Institute. The scientists, using the gathered data, crafted an mRNA vaccine tailored exactly to Rosie’s condition.
This type of vaccine works by giving cells the “instructions” to produce proteins that the immune system can recognize and fight against. In this case, the vaccine was precisely customized according to the genetic changes in the dog's tumor.
The result surprised even the scientists, as the tumor shrank to about half its size. According to experts, this could be one of the first examples of such personalized treatment in a dog.
